Skip to main content

Table 1 Number of responders and nonresponders to insulin glargine 100 Units/mL at 24 weeks by composite HbA1c endpoint

From: Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials

HbA1c < 7% (Yes/No) ≥1% reduction in HbA1c (Yes/No) Responders
(HbA1c < 7% or ≥ 1% reduction)
n (%)
Nonresponders
(HbA1c ≥ 7% and < 1% reduction)
n (%)
Yes Yes 595 (50)
Yes No 88 (7)
No Yes 505 (43)
No No   297 (20)
Total (N = 1485) 1188 (80) 297 (20)
  1. Abbreviation: HbA1c glycated hemoglobin